Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 3.
doi: 10.1245/s10434-025-18003-3. Online ahead of print.

ASO Author Reflections: Predictive Factor for Contralateral Lymph Node Involvement in Clinically Unilateral Prostate Cancer

Masaki Shiota  1 , Shigehiro Tsukahara  2 , Tokiyoshi Tanegashima  2 , Jun Mutaguchi  2 , Shunsuke Goto  2 , Satoshi Kobayashi  2 , Takashi Matsumoto  2 , Masatoshi Eto  2
Affiliations

ASO Author Reflections: Predictive Factor for Contralateral Lymph Node Involvement in Clinically Unilateral Prostate Cancer

Masaki Shiota et al. Ann Surg Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure: Masatoshi Eto reports honoraria for lectures from Astellas Pharma, AstraZeneca, Bayer Yakuhin, Bristol Myers Squibb, Eisai, Janssen Pharmaceutical, Merck Biopharma, Novartis, MSD, Ono Pharmaceutical, Pfizer, and Takeda Pharmaceutical and research funding from MSD.

References

    1. Shiota M, Blas L, Eto M. Current status and future perspective on the management of lymph node-positive prostate cancer after radical prostatectomy. Cancers (Basel). 2022;14:2696.
    1. Shiota M, Shimbo M, Tsukahara S, Tanegashima T, Mutaguchi J, Goto S, et al. Optimization of extended pelvic lymph node dissection side for prostate cancer. Ann Surg Oncol. 2024;31:8986–92.
    1. Martini A, Wever L, Soeterik TFW, Rakauskas A, Fankhauser CD, Grogg JB, et al. Unilateral pelvic lymph node dissection in prostate cancer patients diagnosed in the era of magnetic resonance imaging-targeted biopsy: a study that challenges the dogma. J Urol. 2023;210:117–27.
    1. Shiota M, Tsukahara S, Tanegashima T, Mutaguchi J, Goto S, Kobayashi S, et al. Prediction of contralateral lymph node involvement during extended pelvic lymph node dissection for clinically unilateral prostate cancer. Ann Surg Oncol. 2025. https://doi.org/10.1245/s10434-025-17840-6

LinkOut - more resources